{
  "id": 10910696,
  "title": "People switching to Novo's Wegovy pill from obesity injections kept losing weight in real-world study",
  "url": "https://urgent.news/2026/09/30/people-switching-to-novos-wegovy-pill-from-obesity-injections-kept",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-30T09:45:01.000Z",
  "source": {
    "name": "CNBC",
    "slug": "cnbc",
    "url": "https://www.cnbc.com/2026/09/30/novo-wegovy-pill-weight-loss-injections.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "People who switched to Novo's Wegovy pill from obesity injections continued to lose weight in a real-world study. According to CNBC, this suggests that patients may not need to take weekly injections forever and can opt for more convenient treatments.\n\nThe effectiveness of obesity treatments is being explored in various studies. Researchers published late-stage clinical trial data for retatrutide, an obesity drug, in Ars Technica and Ars Technica Health. The trial included 2,339 participants from 131 clinical trial sites in 11 countries. Participants taking the highest retatrutide dose lost an average of 25 percent of their body weight after 80 weeks and 30 percent after an extension period to 104 weeks. More than a third of participants taking retatrutide lost 30 percent or more of their weight.\n\nNovo is also involved in licensing deals for obesity treatments. According to STAT News, Novo agreed to pay up to $2.6 billion to license an experimental, weekly weight loss pill from China’s Hengrui Pharma. Additionally, BioPharma Dive reported that Novo acquired a challenger to Lilly’s market-leading Zepbound.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 3,
    "also_reported_by": [
      {
        "outlet": "Ars Technica Health",
        "title": "Most powerful obesity drug yet: People lost up to 25% of weight in trial",
        "url": "https://urgent.news/2026/09/29/most-powerful-obesity-drug-yet-people-lost-up-to-25-of-weight-in-trial",
        "published": "2026-09-29T22:30:37.000Z"
      },
      {
        "outlet": "CNBC World",
        "title": "People switching to Novo's Wegovy pill from obesity injections kept losing weight in real-world study",
        "url": "https://urgent.news/2026/09/30/people-switching-to-novos-wegovy-pill-from-obesity-injections-kept-10917920",
        "published": "2026-09-30T09:45:01.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}